“gloucester-pharmaceuticals” Archives

Entry Author Date Location
Harvard’s Verdine Aims to Retire, Become Full-Time FogPharma CEO 02/23/17 Boston
With Latest Startup, Harvard’s Verdine Again Aims at Elusive Targets 04/13/16 Boston
Ex-Alnylam Exec to Steer Warp Drive Bio; Verdine Shifts Roles 03/04/15 Boston
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
Harvard Professor Steps Down to Pilot Warp Drive Bio 07/02/13 Boston
Acetylon, Backed by Patriots Owner Bob Kraft, Snags $27M to Develop New Cancer Drugs 06/29/11 Boston
Accelerator Reaches Out to East Coast to Find Latest Startup, Acylin Therapeutics 12/01/10 Seattle
Onyx Preps for Dash to FDA, After Myeloma Drug Helps Sickest of the Sick 07/26/10 San Francisco
Is the Venture Model Really Broken? 05/12/10 Boston
Avalon Stakes Claim as Survivor Among San Diego Biotech VCs 04/12/10 San Diego
5AM Gathers $200M Fund, Advanced Cell Technology Advances with $2.8 Million, Gloucester Picked up for $640M, & More Boston-Area Deals News 12/11/09 Boston
A Graceful Exit for Gloucester, Pink Slips at Sermo, A Half a Billion Bucks for Vertex, & More Boston-Area Life Sciences News 12/09/09 Boston
Celgene Agrees to Acquire Gloucester Pharma for $340M Cash Upfront, $300M Later 12/07/09 Boston
Celgene Corporation Acquires Gloucester Pharmaceuticals for $640,000,000 12/07/09 Boston
Ironwood Nabs $75M in Deal With Japanese Firm, Gloucester Drug Gets FDA Approval, Alnylam Branches Into Biomanufacturing Tech, & More Boston-Area Life Sciences News 11/13/09 Boston
Gloucester Pharma Wins FDA Approval of Drug for Rare Skin Cancer 11/05/09 Boston
Top 10 (+ 1) New England Venture Deals of Q3 2009 10/20/09 Boston
Funding for Massachusetts Startups Slower, but Still Strong, in August; Early-Stage Deals Predominate 09/14/09 Boston
Federal Judge Rules in Biogen Idec’s Favor, Sepracor Agrees to $2.8B Buyout, FDA Panel Endorses Gloucester Pharma Drug, & More Boston-Area Life Sciences News 09/11/09 Boston
Gloucester Wins Recommendation from FDA Panel for Lymphoma Drug 09/02/09 Boston
Gloucester Gears Up for FDA Panel Vote on Lymphoma Drug 09/02/09 Boston
Heartland Robotics Lands $7M, Gloucester Pharma Gets $29M, Biopure Auctioned Away for $4M, & More Boston Deals News 08/28/09 Boston
Resolvyx Nails Dry Eye Trial, Gloucester Pulls in $29M, Shire Beefs Up Mass Presence, & Other Boston-Area Life Sciences News 08/26/09 Boston
Gloucester Nails Down $29M to Move Ahead with Late-Stage Cancer Drug 08/24/09 Boston
Blood News: A Quick Rundown of Headlines From the American Society of Hematology 12/09/08 National
Gloucester Drug Shrinks Tumors in Lymphoma Study 12/08/08 Boston
Page 1 of 1